Skip to main content
CCSB logo

CCSB — Investor Relations & Filings

Ticker · 1762 ISIN · TW0001762003 TW Manufacturing
Open in API
Filings indexed 1,608 across all filing types
Latest filing 2024-02-07 Regulatory Filings
Country TW Taiwan
Listing TW 1762

About CCSB

www.ccsb.com.tw

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) with a history dating back to 1964. The company focuses on the research, development, and large-scale production of high-quality APIs, particularly in the therapeutic areas of oncology, antifungal treatments, and immunosuppressants. CCSB offers a broad service portfolio that includes cGMP-compliant contract manufacturing and toll manufacturing. By leveraging advanced chemical synthesis and biotechnology platforms, the company provides tailored solutions to global pharmaceutical partners. CCSB adheres to rigorous international quality standards and environmental, health, and safety protocols, ensuring the reliable supply of critical medicinal components for the global healthcare market.

Recent filings

Filing Released Lang Actions
113年1月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 中化生, reporting on the status of fund loans and endorsement guarantees for the current and previous month, with amounts all zero. It contains no detailed financial statements, no management discussion, no audit information, no voting results, no legal proceedings, and no mention of any report publication. The document is very short (602 characters) and appears to be a regulatory disclosure of financial status related to guarantees and loans. This type of document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-02-07 Chinese
113年1月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summarized financial data report showing monthly and cumulative net operating revenue figures for a company named 中化生 for January of the 113th year of the Republic of China calendar (equivalent to 2024). It includes percentage changes compared to the previous year and explanations for revenue changes. The document is very short (797 characters) and primarily presents key financial figures without detailed financial statements or management discussion. It resembles a brief factsheet or summary of financial data rather than a full report or announcement. There is no indication of it being an earnings release, annual or interim report, or any regulatory filing. Given the concise nature and focus on key financial facts, the best fitting category is Fund Information / Factsheet (FS).
2024-02-07 Chinese
113年01月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings and changes in share ownership by insiders, including directors, senior management, and related parties. It includes data on shares held, increases, decreases, and trust shares. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of a full financial report, earnings release, or meeting materials. The document is not a brief announcement but a detailed insider shareholding report. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is sufficient and the content is consistent with insider shareholding disclosures.
2024-02-01 Chinese
113年01月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, supervisors, and senior management, showing their current holdings, pledged shares, and related party holdings. It is a disclosure of insider shareholdings and pledges rather than a financial report, meeting announcement, or voting result. The document length is 3018 characters, which is relatively short and focused solely on insider shareholding data. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions or holdings by company directors and executives. There is no indication of financial results, meeting materials, or other report types. Therefore, the appropriate classification is DIRS.
2024-02-01 Chinese
112年12月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 中化生, providing information about fund lending balances and endorsement guarantees for the current and previous month, with all values being zero. It contains no detailed financial statements, no management discussion, no audit information, no voting results, no legal proceedings, and no mention of any report publication. The content is regulatory in nature, reporting compliance-related financial data but not constituting a full report or announcement of a report. The document length is very short (602 characters), and it does not indicate it is an announcement of a report publication. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2024-01-10 Chinese
112年12月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summarized revenue report from a listed company, showing monthly and cumulative net operating revenue figures with year-over-year comparisons. It includes notes on accounting standards (IFRS) and reporting practices. The document is short (776 characters) and primarily provides financial data for a specific period (December of the 112th year in the ROC calendar, equivalent to 2023). It does not appear to be a full annual or interim report but rather a brief financial summary. Given the nature of the content as a brief summary of key financial facts and figures, it fits best into the Fund Information / Factsheet (FS) category, which is for brief summaries of key company facts and financials.
2024-01-10 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.